Two workers who had skin exposure to a concentrated dichlorvos formulation, and failed to wash it off, died of poisoning
Regulatory decisions regarding GLP-1 agonists reflect the ongoing dialogue between pharmaceutical companies, regulatory agencies, and the medical community to ensure the availability of safe and effective treatment options for patients in need
Arthritis gone. Nicholas Tower Wegovy is brilliant and works so well
And as you know, theyve created these subsidiary companies called GPOs, where they have the GPO, who, in two out of three cases is based offshore, and that company negotiates with the manufacturer, and then the GPO, after getting a price with the manufacturer, then negotiates with the PBM but keeps part of the profits themselves, so that the GPO retains profits, and that gives the PBM the plausible deniability to employers to say, Oh no, we pass through our entire rebate when, in reality, they dont